Press Releases

Search | News by Email

All Releases
View Summary DexCom Schedules Second Quarter 2017 Earnings Release and Conference Call for August 1, 2017 at 4:30 p.m. Eastern Time
Jun 20, 2017
PDF 14.2 KB Add to Briefcase
View Summary New Study Shows Adults with Type 1 and Type 2 Diabetes on Multiple Daily Injections (MDI) Benefit from CGM
Jun 9, 2017
PDF 26.1 KB Add to Briefcase
View Summary Dexcom to Add Ambulatory Glucose Profile (AGP) to Dexcom CLARITY®
Jun 8, 2017
PDF 57.1 KB Add to Briefcase
View Summary DexCom Announces FDA Approval of G5 Mobile App for Android Devices
Jun 7, 2017
PDF 15.6 KB Add to Briefcase
View Summary DexCom Announces Upcoming Conference Presentation
May 15, 2017
PDF 16.1 KB Add to Briefcase
View Summary DexCom Prices Offering of $350 Million of 0.75% Convertible Senior Notes
May 8, 2017
PDF 18.0 KB Add to Briefcase
View Summary DexCom Announces Proposed Offering of $300 Million of Convertible Senior Notes
May 8, 2017
PDF 17.3 KB Add to Briefcase
View Summary DexCom, Inc. Reports First Quarter 2017 Financial Results
May 2, 2017
PDF 25.3 KB Add to Briefcase
View Summary Medicare Announces Criteria Covering Dexcom G5 Mobile CGM for All People with Diabetes on Intensive Insulin Therapy
Mar 24, 2017
PDF 24.2 KB Add to Briefcase
View Summary DexCom Schedules First Quarter 2017 Earnings Release and Conference Call for May 2, 2017 at 4:30 p.m. Eastern Time
Mar 23, 2017
PDF 14.2 KB Add to Briefcase
View Summary DexCom Appoints Richard Collins to Board of Directors
Mar 13, 2017
PDF 16.2 KB Add to Briefcase
View Summary DexCom, Inc. Reports Fourth Quarter and Fiscal Year 2016 Financial Results
Feb 28, 2017
PDF 31.1 KB Add to Briefcase
View Summary DexCom Announces Upcoming Conference Presentations
Feb 22, 2017
PDF 16.8 KB Add to Briefcase
View Summary Dexcom announces publication of key study in the Journal of the American Medical Association (JAMA) demonstrating the value of CGM in reducing A1C and hypoglycemia in diabetes patients on injection therapy
Jan 24, 2017
PDF 138.7 KB Add to Briefcase
View Summary DexCom Schedules Fourth Quarter and Full Year 2016 Earnings Release and Conference Call for February 28, 2017 at 4:30 p.m. Eastern Time
Jan 23, 2017
PDF 14.2 KB Add to Briefcase
View Summary Centers for Medicare & Medicaid Services (CMS) Classify Therapeutic Continuous Glucose Monitors (CGM) as "Durable Medical Equipment" under Medicare Part B
Jan 12, 2017
PDF 20.7 KB Add to Briefcase
View Summary The launch of Dexcom Canada will reshape how Canadians living with diabetes access and use continuous glucose monitoring
Jan 11, 2017
PDF 40.2 KB Add to Briefcase
View Summary DexCom Reports Record Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2016 and Provides Initial 2017 Outlook
Jan 10, 2017
PDF 16.9 KB Add to Briefcase
View Summary FDA Approval of Dexcom's Non-Adjunctive Indication Triggers a New Era in Diabetes Management
Dec 20, 2016
PDF 20.7 KB Add to Briefcase
View Summary DexCom Announces Upcoming Conference Presentation
Dec 19, 2016
PDF 16.7 KB Add to Briefcase
Showing 1-20 of 302 Page: 1 2 3 4 5 ... 16  Next 20
Add to Briefcase = add release to Briefcase